Hodgkin Disease Study
COG #AHOD0431: A Phase III Study for the treatment of children and adolescents with newly diagnosed low risk Hodgkin disease
Protocol ID
Protocol Description
Hodgkin disease is one of the most treatable and curable childhood cancers. The standard treatment for Hodgkin disease involves chemotherapy and radiation therapy. Although subjects are cured of their cancer, some experience bad effects from treatment later in life. It is thought that if some subjects can be successfully treated with less intense therapy, those subjects might have less bad effects later in life. The goals of the study are:
• To find out if subjects who respond well to chemotherapy alone can be treated successfully without radiation therapy; and
• To see if subjects who relapse after chemotherapy alone can be treated successfully with less intensive treatment than standard relapse treatment.
Eligibility Criteria
Children and adolescents with Hodgkin disease
Primary Investigator(s)
- Arlene Redner, MD